Page last updated: 2024-08-18

benzothiazole and Akinetic-Rigid Variant of Huntington Disease

benzothiazole has been researched along with Akinetic-Rigid Variant of Huntington Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnickel, G; Boeddrich, A; Böttcher, H; Bröcker, W; Dunkel, I; Engemann, S; Heiser, V; Herhaus, C; Lehrach, H; Lurz, R; Nordhoff, E; Rautenberg, S; Schugardt, N; Waelter, S; Wanker, EE1
Barker, AL; Bates, GP; Beunard, JL; Hockly, E; Holt, K; Lowden, PA; Moffitt, H; Moolman, DL; Revington, AP; Sathasivam, K; Sunshine, S; Tse, J; Wanker, EE; Woodman, B1

Other Studies

2 other study(ies) available for benzothiazole and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, Dec-10, Volume: 99 Suppl 4

    Topics: Benzothiazoles; Blotting, Western; Cell Line; Electrophoresis, Polyacrylamide Gel; Exons; Fluorescent Antibody Technique, Indirect; Humans; Huntingtin Protein; Huntington Disease; Microscopy, Electron; Nerve Tissue Proteins; Nuclear Proteins; Peptides; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Thiazoles

2002
Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease.
    Neurobiology of disease, 2006, Volume: 21, Issue:1

    Topics: Animals; Benzothiazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Genotype; Huntington Disease; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Neuroprotective Agents; Organ Culture Techniques; Riluzole; Thiazoles

2006